CVS HEALTH Corp — Director's Dealing 2020

Mar 3, 2020

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: CVS HEALTH Corp (CVS)
CIK: 0000064803
Period of Report: 2020-02-28

Reporting Person: Clark James David (SVP, Cont & Chief Acct Officer)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2020-02-28	Common Stock	F	347	$59.18	Disposed	9760.2554	Direct
2020-02-28	Common Stock (restricted)	A	1912	$59.18	Acquired	14733	Direct

Footnotes

F1: Surrender of shares in payment of withholding taxes due upon the vesting of a restricted stock award.

F2: Consists of Restricted Stock Units awarded pursuant to Issuer's 2017 Incentive Compensation Plan its Performance-Based Restricted Stock Unit Plan. Restrictions lapse in three equal installments, commencing February 28, 2021.